Neurodegenerative Disease News and Research

RSS

Sino Biological launches precisely characterized full-length p-Tau217 protein to advance next-generation Alzheimer’s Biomarker assay development

Sino Biological Inc. is pleased to announce the launch of its Recombinant Human p-Tau217 Protein (Cat. No. T08-50SN), a full-length, tag-free Tau reagent developed to support Alzheimer’s disease biomarker assay development, antibody evaluation, and Tau biology research.

From Sino Biological Inc. 4 Aug 2026

New AI model generates detailed maps of aging in brain regions

USC researchers have developed an approach that uses artificial intelligence to generate detailed maps that highlight differences in how distinct parts of the brain age.

3 Aug 2026

Daytime cortisol patterns track cognitive decline but not Alzheimer’s disease risk

In 3,895 older adults, moderate daytime cortisol variability was associated with better cognition and slower decline, while the highest daily cortisol exposure was linked to poorer cognition and faster decline. Cortisol patterns differed between Black and White participants, but their relationships with cognition were similar, and none predicted incident Alzheimer’s disease.

2 Aug 2026

Psychological barriers limit prescribing of new neurodegenerative treatments

A new pan-European study has identified the key behavioral factors that influence whether healthcare professionals prescribe new, novel or non-routine treatments for patients with neurodegenerative diseases.

28 Jul 2026

Study reveals dynamic remodeling of genome architecture during brain aging

Researchers have discovered that the human brain undergoes widespread age-related changes in genome regulation beginning in midlife that may help explain why aging is the greatest risk factor for neurodegenerative diseases such as Alzheimer's.

23 Jul 2026

New study uses sleep monitoring and AI to detect Alzheimer's

Researchers from Universidad Carlos III de Madrid (UC3M) and Hospital Universitario Severo Ochoa in Leganés, part of the public health network of the Comunidad de Madrid, have developed a methodology that uses artificial intelligence (AI) to analyze brain electrical activity during sleep and facilitate the early diagnosis of Alzheimer's.

22 Jul 2026

UC San Diego and IGI join hands to develop advanced genome-editing tools and applications

The University of California San Diego and the Innovative Genomics Institute (IGI), founded by Nobel laureate and CRISPR gene editing co-discoverer Jennifer Doudna, announced a new partnership today to jointly develop cutting-edge genomic tools for addressing large-scale challenges in health and the environment.

21 Jul 2026

Tau buildup in progressive supranuclear palsy alters brain networks linked to thinking and behavior

Researchers at Japan's National Institutes for Quantum Science and Technology (QST) have found that tau buildup in progressive supranuclear palsy (PSP) may affect brain networks involved in thinking and behavior.

17 Jul 2026

Study suggests lipid droplet accumulation is a conserved feature of senescent cells

A new research paper was published in Volume 18 of Aging on July 1, 2026, titled "Senescent cells accumulate lipid droplets."

16 Jul 2026

Brain’s immune cells play key role in maintaining stability of neuronal networks in Alzheimer's disease

Researchers at Trinity College Dublin have discovered that microglia – the main immune cells of the brain – play a critical role in maintaining the stability of neuronal networks in Alzheimer's disease.

15 Jul 2026

New review highlights astrocytes' role in chronic traumatic encephalopathy

Researchers from Kansas City University School of Medicine have published a scoping review examining the role of astrocytes in chronic traumatic encephalopathy (CTE).

14 Jul 2026

Imaging technique uncovers how copper imbalance may contribute to neurodegenerative diseases

Using a groundbreaking imaging technique, a University of Houston chemist is uncovering how copper imbalances in the body may contribute to neurodegenerative diseases such as Alzheimer's, Parkinson's and ALS.

13 Jul 2026

Stem cell-derived dopaminergic cell transplantation shows encouraging results for Parkinson's disease

The International Society for Stem Cell Research (ISSCR) today announced the presentation of new clinical data from the STEM-PD Phase I/II clinical trial at the ISSCR 2026 Annual Meeting.

9 Jul 2026

Damaged myelin alters sleep brain rhythms in neurological diseases

Scientists have discovered how damage to the myelin sheath – the insulating layer around nerve fibres – affects brain activity during sleep.

9 Jul 2026

Spear Bio to unveil novel Alzheimer’s disease immunoassays and fully automated instrument platform at AAIC 2026

Spear Bio, an innovator in ultrasensitive protein biomarker detection, today announced plans to unveil new SPEAR immunoassay and instrument innovations at the Alzheimer’s Association International Conference® 2026, taking place July 12–15 in London, UK.

From Spear Bio 9 Jul 2026

Study identifies new target for Parkinson's disease neuroprotection

Parkinson's disease (PD) is the second most common form of neurodegenerative disease and afflicts more than ten million people worldwide. While current therapies address disease symptoms, they do not prevent the underlying neurodegeneration that drives the disease.

8 Jul 2026

Study reveals how glial cells regulate brain injury and recovery

Traumatic brain injury (TBI) affects millions of people worldwide every year and remains a major cause of long-term disability, cognitive decline, and neurological complications.

8 Jul 2026

NFL players have higher rates of neurodegenerative disease-caused mortality

Mass General Brigham, Boston University, and the Concussion & CTE Foundation cohort study of nearly 20,000 NFL players reveals that players are dying of dementia and Parkinson's disease at much higher rates than the general population.

8 Jul 2026

Short sleep and poor sleep quality track with Parkinson’s risk

Using CHARLS data from 2011 to 2020, researchers found that sleep duration and self-reported sleep quality were associated with Parkinson’s disease risk in middle-aged and older Chinese adults. Short sleep was linked to higher PD risk, while age-specific patterns suggested a linear association in adults aged ≤60 years and a U-shaped relationship in those aged >60 years.

6 Jul 2026

Study identifies promising drug target to prevent neurodegenerative conditions

6 Jul 2026

Neurodegenerative Disease News and Research

Sino Biological launches precisely characterized full-length p-Tau217 protein to advance next-generation Alzheimer’s Biomarker assay development

New AI model generates detailed maps of aging in brain regions

Daytime cortisol patterns track cognitive decline but not Alzheimer’s disease risk

Psychological barriers limit prescribing of new neurodegenerative treatments

Study reveals dynamic remodeling of genome architecture during brain aging

New study uses sleep monitoring and AI to detect Alzheimer's

UC San Diego and IGI join hands to develop advanced genome-editing tools and applications

Tau buildup in progressive supranuclear palsy alters brain networks linked to thinking and behavior

Study suggests lipid droplet accumulation is a conserved feature of senescent cells

Brain’s immune cells play key role in maintaining stability of neuronal networks in Alzheimer's disease

New review highlights astrocytes' role in chronic traumatic encephalopathy

Imaging technique uncovers how copper imbalance may contribute to neurodegenerative diseases

Stem cell-derived dopaminergic cell transplantation shows encouraging results for Parkinson's disease

Damaged myelin alters sleep brain rhythms in neurological diseases

Spear Bio to unveil novel Alzheimer’s disease immunoassays and fully automated instrument platform at AAIC 2026

Study identifies new target for Parkinson's disease neuroprotection

Study reveals how glial cells regulate brain injury and recovery

NFL players have higher rates of neurodegenerative disease-caused mortality

Short sleep and poor sleep quality track with Parkinson’s risk

Study identifies promising drug target to prevent neurodegenerative conditions

Human iPSCs: A Full Guide to Advanced in Vitro Models and Applications eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News